Delivery Order SPE2DB24D2011-SPE2DB25FBRPA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,542.84 to AmerisourceBergen Drug Corp for the supply of Mupirocin 2% Cream in 15-gram units. This contract, awarded on August 7, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The award was not designated as a set-aside contract, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $2,629.03 to AmerisourceBergen Drug Corp for Mupirocin 2% Cream in 15-gram units. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this work at its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- This federal contract award, valued at $1,704.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Cream, a topical antibiotic medication, with an ultimate completion date of April 11, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment (22 grams) with a ceiling value of $1,897.94 under a Firm Fixed Price contract type. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order falls...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,153.12, is for the delivery of Mupirocin 2% Ointment, a topical antibiotic medication, to support federal healthcare programs. The contract is a firm-fixed-price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,379.87 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4565662415 - Mupirocin 2% Cream 15GM. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical supplies to support military healthcare programs and facilities worldwide. The...
- This federal contract award, valued at $1,660.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Ointment, a topical antibiotic medication, to support military healthcare programs. The contract has an ultimate completion date of May 30, 2024 and is structured as a Firm Fixed Price Delivery Order, without any set-aside designation....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $1,851.13, is for the supply of Mupirocin 2% Cream, a topical antibiotic medication, to support military and federal healthcare programs. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The delivery order, valued at $29,265.91, is for the supply of Mupirocin 2% Cream 15gm, a specialty pharmaceutical product. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor on this award, which has a period of performance through March 20,...
- This contract award, valued at $4,284.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Cream, a topical antibiotic medication, with a completion date of January 31, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRPADelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,688.98 for Mupirocin 2% Cream 15GM, a topical antibiotic medication commonly used for treating bacterial skin infections in military and federal healthcare settings. This firm fixed price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside restrictions. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The award reflects AmerisourceBergen's demonstrated capability to compete successfully for federal pharmaceutical procurement through DLA's open competition process.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/14/25 |